{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:53:37Z","timestamp":1781250817755,"version":"3.54.1"},"reference-count":73,"publisher":"Japan Society of Smooth Muscle Research","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Smooth Muscle Res","J. Smooth Muscle Res."],"published-print":{"date-parts":[[2023]]},"DOI":"10.1540\/jsmr.59.67","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T22:52:42Z","timestamp":1694040762000},"page":"67-80","source":"Crossref","is-referenced-by-count":3,"title":["Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach"],"prefix":"10.1540","volume":"59","author":[{"given":"Senthilkumar","family":"Preethy","sequence":"first","affiliation":[{"name":"Fujio-Eiji Academic Terrain (FEAT), Nichi-In Centre for Regenerative Medicine (NCRM), B-34, LICET, Loyola College, Nungambakkam, Chennai 600034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Genome Medical Sciences Project, National Center for Global Health and Medicine (NCGM), 1 Chome-7-1 Kounodai, Ichikawa-shi, Chiba 272-8516, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ozasa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kumamoto University Hospital, 1 Chome-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadalraja","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Jesuit Antonyraj Memorial Inter-disciplinary Centre for Advanced Recovery and Education (JAICARE), Mandela Nagar, Madurai, Tamil Nadu 625022, India"},{"name":"Department of Paediatric Neurology, Sarvee Integra Private Limited, 61 Bhimasena Garden Street, Mylapore, Chennai 600004, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidyasagar Devaprasad","family":"Dedeepiya","sequence":"additional","affiliation":[{"name":"Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), C-30 LICET, Loyola College, Nungambakkam, Chennai 600034, Chennai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Centre for Advancing Clinical Research (CACR), School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel JK","family":"Abraham","sequence":"additional","affiliation":[{"name":"Mary-Yoshio Translational Hexagon (MYTH), Nichi-In Centre for Regenerative Medicine (NCRM), C-30 LICET, Loyola College, Nungambakkam, Chennai 600034, Chennai, India"},{"name":"Centre for Advancing Clinical Research (CACR), School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan"},{"name":"Antony-Xavier Interdisciplinary Scholastics (AXIS), GN Corporation Co. Ltd., 3-8 Wakamatsu, Kofu, Yamanashi 400-0866, Japan"},{"name":"R & D, Sophy Inc., 248 Tamura, Niyodogawa, Agawa, Kochi 781-1522, Japan"},{"name":"Levy-Jurgen Transdisciplinary Exploratory (LJTE), Global Niche Corp, Wilmington, DE 19805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"435","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Duan, D, Goemans, N, Takeda, S, Mercuri, E, Aartsma-Rus, A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021; 7(1): 13.","DOI":"10.1038\/s41572-021-00248-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gao, QQ, McNally, EM. The dystrophin complex: structure, function, and implications for therapy. Compr Physiol. 2015; 5(3): 1223\u201339.","DOI":"10.1002\/cphy.c140048"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yao, S, Chen, Z, Yu, Y, Zhang, N, Jiang, H, Zhang, G, et al. Current pharmacological strategies for Duchenne muscular dystrophy. Front Cell Dev Biol. 2021; 9: 689533.","DOI":"10.3389\/fcell.2021.689533"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Asher, DR, Thapa, K, Dharia, SD, Khan, N, Potter, RA, Rodino-Klapac, LR, et al. Clinical development on the frontier: gene therapy for duchenne muscular dystrophy. Expert Opin Biol Ther. 2020; 20(3): 263\u201374.","DOI":"10.1080\/14712598.2020.1725469"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Echevarr\u00eda, L, Aupy, P, Goyenvalle, A. Exon-skipping advances for Duchenne muscular dystrophy. Hum Mol Genet. 2018; 27(R2): R163\u201372.","DOI":"10.1093\/hmg\/ddy171"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Malik, V, Rodino-Klapac, LR, Viollet, L, Wall, C, King, W, Al-Dahhak, R, et al. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol. 2010; 67(6): 771\u201380.","DOI":"10.1002\/ana.22024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zhang, Y, Li, H, Min, YL, Sanchez-Ortiz, E, Huang, J, Mireault, AA, et al. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Sci Adv. 2020; 6(8): eaay6812.","DOI":"10.1126\/sciadv.aay6812"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bengtsson, NE, Hall, JK, Odom, GL, Phelps, MP, Andrus, CR, Hawkins, RD, et al. Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat Commun. 2017; 8: 14454.","DOI":"10.1038\/ncomms14454"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Guiraud, S, Edwards, B, Babbs, A, Squire, SE, Berg, A, Moir, L, et al. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Hum Mol Genet. 2019; 28(13): 2189\u2013200.","DOI":"10.1093\/hmg\/ddz049"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kodippili, K, Thorne, PK, Laughlin, MH, Duan, D. Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy. J Pathol. 2021; 254(5): 589\u2013605.","DOI":"10.1002\/path.5704"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kaplan, KM, Morgan, KG. The importance of dystrophin and the dystrophin associated proteins in vascular smooth muscle. Front Physiol. 2022; 13: 1059021.","DOI":"10.3389\/fphys.2022.1059021"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ito, K, Kimura, S, Ozasa, S, Matsukura, M, Ikezawa, M, Yoshioka, K, et al. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum Mol Genet. 2006; 15(14): 2266\u201375.","DOI":"10.1093\/hmg\/ddl151"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Xu, X, Wilschut, KJ, Kouklis, G, Tian, H, Hesse, R, Garland, C, et al. Human satellite cell transplantation and regeneration from diverse skeletal muscles. Stem Cell Reports. 2015; 5(3): 419\u201334.","DOI":"10.1016\/j.stemcr.2015.07.016"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Altamirano, F, L\u00f3pez, JR, Henr\u00edquez, C, Molinski, T, Allen, PD, Jaimovich, E. Increased resting intracellular calcium modulates NF-\u03baB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes. J Biol Chem. 2012; 287(25): 20876\u201387.","DOI":"10.1074\/jbc.M112.344929"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaplan, KM, Morgan, KG. The importance of dystrophin and the dystrophin associated proteins in vascular smooth muscle. Front Physiol. 2022; 13: 1059021.","DOI":"10.3389\/fphys.2022.1059021"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Podkalicka, P, Mucha, O, Dulak, J, Loboda, A. Targeting angiogenesis in Duchenne muscular dystrophy. Cell Mol Life Sci. 2019; 76(8): 1507\u201328.","DOI":"10.1007\/s00018-019-03006-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ennen, JP, Verma, M, Asakura, A. Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle. 2013; 3(1): 9.","DOI":"10.1186\/2044-5040-3-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Verhaart, IEC, Johnson, A, Thakrar, S, Vroom, E, De Angelis, F, Muntoni, F, et al. Muscle biopsies in clinical trials for Duchenne muscular dystrophy\u2014patients\u2019 and caregivers\u2019 perspective. Neuromuscul Disord. 2019; 29(8): 576\u201384.","DOI":"10.1016\/j.nmd.2019.06.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Augier, N, Boucraut, J, L\u00e9ger, J, Anoal, M, Nicholson, LV, Voelkel, MA, et al. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence. J Neurol Sci. 1992; 107(2): 233\u20138.","DOI":"10.1016\/0022-510X(92)90294-U"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Brozovich, FV, Nicholson, CJ, Degen, CV, Gao, YZ, Aggarwal, M, Morgan, KG. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol Rev. 2016; 68(2): 476\u2013532.","DOI":"10.1124\/pr.115.010652"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Heusch, G, Libby, P, Gersh, B, Yellon, D, B\u00f6hm, M, Lopaschuk, G, et al. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet. 2014; 383(9932): 1933\u201343.","DOI":"10.1016\/S0140-6736(14)60107-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Brown, DI, Griendling, KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015; 116(3): 531\u201349.","DOI":"10.1161\/CIRCRESAHA.116.303584"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tabas, I, Garc\u00eda-Carde\u00f1a, G, Owens, GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015; 209(1): 13\u201322.","DOI":"10.1083\/jcb.201412052"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Coral-Vazquez, R, Cohn, RD, Moore, SA, Hill, JA, Weiss, RM, Davisson, RL, et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 1999; 98(4): 465\u201374.","DOI":"10.1016\/S0092-8674(00)81975-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gumerson, JD, Michele, DE. The dystrophin-glycoprotein complex in the prevention of muscle damage. J Biomed Biotechnol. 2011; 2011: 210797.","DOI":"10.1155\/2011\/210797"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Uryash, A, Mijares, A, Est\u00e8ve, E, Adams, JA, Lopez, JR. Smooth muscle cells of dystrophic (mdx) mice are more susceptible to hypoxia; the protective effect of reducing Ca2+<\/sup> influx. Biomedicines. 2023; 11(2): 623.","DOI":"10.3390\/biomedicines11020623"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sharma, P, Basu, S, Mitchell, RW, Stelmack, GL, Anderson, JE, Halayko, AJ. Role of dystrophin in airway smooth muscle phenotype, contraction and lung function. PLoS One. 2014; 9(7): e102737.","DOI":"10.1371\/journal.pone.0102737"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sykes, BG, Van Steyn, PM, Vignali, JD, Winalski, J, Lozier, J, Bell, WE, et al. The relationship between estrogen and nitric oxide in the prevention of cardiac and vascular anomalies in the developing zebrafish (Danio Rerio). Brain Sci. 2016; 6(4): 51.","DOI":"10.3390\/brainsci6040051"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nichols, B, Takeda, S, Yokota, T. Nonmechanical roles of dystrophin and associated proteins in exercise, neuromuscular junctions, and brains. Brain Sci. 2015; 5(3): 275\u201398.","DOI":"10.3390\/brainsci5030275"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Rhoads, RP, Flann, KL, Cardinal, TR, Rathbone, CR, Liu, X, Allen, RE. Satellite cells isolated from aged or dystrophic muscle exhibit a reduced capacity to promote angiogenesis in vitro. Biochem Biophys Res Commun. 2013; 440(3): 399\u2013404.","DOI":"10.1016\/j.bbrc.2013.09.085"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rauch, U, Shami, A, Zhang, F, Carmignac, V, Durbeej, M, Hultg\u00e5rdh-Nilsson, A. Increased neointimal thickening in dystrophin-deficient mdx mice. PLoS One. 2012; 7(1): e29904.","DOI":"10.1371\/journal.pone.0029904"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Hassan, FU, Nadeem, A, Li, Z, Javed, M, Liu, Q, Azhar, J, et al. Role of Peroxisome Proliferator-Activated Receptors (PPARs) in energy homeostasis of dairy animals: exploiting their modulation through nutrigenomic interventions. Int J Mol Sci. 2021; 22(22): 12463.","DOI":"10.3390\/ijms222212463"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Manickam, R, Duszka, K, Wahli, W. PPARs and microbiota in skeletal muscle health and wasting. Int J Mol Sci. 2020; 21(21): 8056.","DOI":"10.3390\/ijms21218056"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mahavadi, S, Gorti, A, Manjunath, R, Randhawa, G, Singh, K, Rider, JR, et al. Altered contraction phenotype and smooth muscle function in the intestine of dystrophin-deficient (mdx) mice. Experimental Biology 2019 Meeting Abstracts. .","DOI":"10.1096\/fasebj.2019.33.1_supplement.lb548"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Manickam, R, Oh, HYP, Tan, CK, Paramalingam, E, Wahli, W. Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism. Int J Mol Sci. 2018; 19(8): 2418.","DOI":"10.3390\/ijms19082418"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ikewaki, N, Dedeepiya, VD, Raghavan, K, Rao, KS, Vaddi, S, Osawa, H, et al. \u03b2\u2011glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B\u2011VACCIEN) in specific immunocompromised populations (Review). Oncol Rep. 2022; 47(1): 14.","DOI":"10.3892\/or.2021.8225"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Dedeepiya, VD, Sivaraman, G, Venkatesh, AP, Preethy, S, Abraham, SJ. Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India. Case Rep Med. 2012; 2012: 895370.","DOI":"10.1155\/2012\/895370"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ganesh, JS, Rao, YY, Ravikumar, R, Jayakrishnan, GA, Iwasaki, M, Preethy, S, et al. Beneficial effects of black yeast derived 1-3, 1-6 Beta Glucan-Nichi Glucan in a dyslipidemic individual of Indian origin--a case report. J Diet Suppl. 2014; 11(1): 1\u20136.","DOI":"10.3109\/19390211.2013.859211"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ikewaki, N, Ikeue, Y, Nagataki, M, Kurosawa, G, Dedeepiya, VD, Rajmohan, M, et al. Beneficial effects of 1,3-1,6 \u03b2-glucans produced by Aureobasidium pullulans on non-esterified fatty acid levels in diabetic KKAy mice and their potential implications in metabolic dysregulation. J Diabetes Metab Disord. 2022; 22(1): 487\u201394.","DOI":"10.1007\/s40200-022-01170-5"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ikewaki, N, Raghavan, K, Dedeepiya, VD, Suryaprakash, V, Iwasaki, M, Preethy, S, senthilkumar R, Abraham SJK. Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulans<\/i> AFO-202 and N-163 produced beta glucans in Sprague Dawley rats. Clinical Immunology Communications. 2021; 1: 29\u201334.","DOI":"10.1016\/j.clicom.2021.11.001"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Raghavan, K, Dedeepiya, VD, Suryaprakash, V, Rao, KS, Ikewaki, N, Sonoda, T, et al. Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study. Biomed Pharmacother. 2022; 145: 112243.","DOI":"10.1016\/j.biopha.2021.112243"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Ikewaki, N, Levy, GA, Kurosawa, G, Iwasaki, M, Dedeepiya, VD, Vaddi, S, et al. Hepatoprotective effects of Aureobasidium pullulans<\/i> derived \u03b2 1,3-1,6 glucans in a murine model of non-alcoholic steatohepatitis. J Clin Exp Hepatol. 2022; 12(6): 1428\u201337.","DOI":"10.1016\/j.jceh.2022.06.008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Raghavan, K, Dedeepiya, VD, Srinivasan, S, Pushkala, S, Subramanian, S, Ikewaki, N, et al. Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans<\/i>-produced 1,3\u20131,6 Beta glucans in Duchenne muscular dystrophy: results of an open-label, prospective, exploratory case-control clinical study. IBRO Neurosci Rep. 2023; 15: 90\u20139.","DOI":"10.1016\/j.ibneur.2023.06.007"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Raghavan, K, Sivakumar, T, Bharatidasan, SS, Srinivasan, S, Dedeepiya, VD, Ikewaki, N, et al. Efficacy of N-163 strain of Aureobasidium pullulans-produced beta-glucan in improving muscle strength and function in patients with Duchenne muscular dystrophy; results of a 6-month non-randomised open-label linear clinical trial. medRxiv 2023.04.29.23289260v1.","DOI":"10.1101\/2023.04.29.23289260"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Raghavan, K, Dedeepiya, VD, Yamamoto, N, Ikewaki, N, Iwasaki, M, Dinassing, A, et al. Randomised trial of Aureobasidium pullulans-produced beta 1,3\u20131,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation. medRxiv 2022.12.09.22283273.","DOI":"10.1101\/2022.12.09.22283273"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Kawamoto, S, Uemura, K, Hori, N, Takayasu, L, Konishi, Y, Katoh, K, et al. Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota. Nat Cell Biol. 2023; 25(6): 865\u201376.","DOI":"10.1038\/s41556-023-01145-5"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Jayaraman, A, Pettersson, S. When dysbiosis meets dystrophy: an unwanted gut-muscle connection. EMBO Mol Med. 2023; 15(3): e17324.","DOI":"10.15252\/emmm.202217324"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Preethy, S, Aoki, Y, Minegishi, K, Senthilkumar, R, Abraham, S. Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced biological response modifier \u03b2-glucan (BRMG). bioRxiv 2022.11.17.516628.","DOI":"10.1101\/2022.11.17.516628"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Preethy, S, Sakamoto, S, Higuchi, T, Ichiyama, K, Yamamoto, N, Ikewaki, N, et al. Enhanced muscle regeneration in mdx mice, Duchenne muscular dystrophy animal model, proven by CD44 & MYH3 expression, on oral feeding of N-163 strain of Aureobasidium Pullulans produced B-Glucan. biorxiv 2023.06.06.543858v1.","DOI":"10.1101\/2023.06.06.543858"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Chan, GC, Chan, WK, Sze, DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009; 2: 25.","DOI":"10.1186\/1756-8722-2-25"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Shimizu-Motohashi, Y, Asakura, A. Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells. Front Physiol. 2014; 5: 50.","DOI":"10.3389\/fphys.2014.00050"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Bosco, J, Zhou, Z, Gabri\u00ebls, S, Verma, M, Liu, N, Miller, BK, et al. VEGFR-1\/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Mol Ther Methods Clin Dev. 2021; 21: 369\u201381.","DOI":"10.1016\/j.omtm.2021.03.013"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Preethy, S, Ikewaki, N, Levy, GA, Raghavan, K, Dedeepiya, VD, Yamamoto, N, et al. Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease. BMJ Open Gastroenterol. 2022; 9(1): e000985.","DOI":"10.1136\/bmjgast-2022-000985"},{"key":"54","doi-asserted-by":"publisher","unstructured":"54. Chang, NC, Sincennes, MC, Chevalier, FP, Brun, CE, Lacaria, M, Segal\u00e9s, J, et al. The dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell cmmitment. Cell Stem Cell. 2018; 22(5): 755\u2013768.e6.","DOI":"10.1016\/j.stem.2018.03.022"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Wehling-Henricks, M, Jordan, MC, Gotoh, T, Grody, WW, Roos, KP, Tidball, JG. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One. 2010; 5(5): e10763.","DOI":"10.1371\/journal.pone.0010763"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Thapa, S, Elhadidy, S, Asakura, A. Vascular therapy for Duchenne muscular dystrophy (DMD). Fac Rev. 2023; 12: 3.","DOI":"10.12703\/r\/12-3"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Wehling-Henricks, M, Jordan, MC, Roos, KP, Deng, B, Tidball, JG. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet. 2005; 14(14): 1921\u201333.","DOI":"10.1093\/hmg\/ddi197"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Timpani, CA, Hayes, A, Rybalka, E. Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy. Orphanet J Rare Dis. 2017; 12(1): 100.","DOI":"10.1186\/s13023-017-0652-y"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Matsakas, A, Yadav, V, Lorca, S, Narkar, V. Muscle ERR\u03b3 mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming. FASEB J. 2013; 27(10): 4004\u201316.","DOI":"10.1096\/fj.13-228296"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Serra, F, Quarta, M, Canato, M, Toniolo, L, De Arcangelis, V, Trotta, A, et al. Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve. 2012; 46(5): 773\u201384.","DOI":"10.1002\/mus.23432"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Whitehead, NP, Kim, MJ, Bible, KL, Adams, ME, Froehner, SC. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci USA. 2015; 112(41): 12864\u20139.","DOI":"10.1073\/pnas.1509536112"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Nico, B, Marzullo, A, Corsi, P, Vacca, A, Roncali, L, Ribatti, D. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy. Neuroscience. 2004; 123(3): 585\u20138.","DOI":"10.1016\/j.neuroscience.2003.11.006"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Chun, JL, O\u2019Brien, R, Song, MH, Wondrasch, BF, Berry, SE. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx\/utrn-\/- but not aged mdx mouse models for duchenne muscular dystrophy. Stem Cells Transl Med. 2013; 2(1): 68\u201380.","DOI":"10.5966\/sctm.2012-0107"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Dar, A, Itskovitz-Eldor, J. Therapeutic potential of perivascular cells from human pluripotent stem cells. J Tissue Eng Regen Med. 2015; 9(9): 977\u201387.","DOI":"10.1002\/term.1698"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Pinheiro, CH, de Queiroz, JC, Guimar\u00e3es-Ferreira, L, Vitzel, KF, Nachbar, RT, de Sousa, LG, et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev Rep. 2012; 8(2): 363\u201374.","DOI":"10.1007\/s12015-011-9304-0"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Xuan, W, Khan, M, Ashraf, M. Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle. Stem Cell Res Ther. 2021; 12(1): 131.","DOI":"10.1186\/s13287-021-02174-3"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Torrente, Y, Belicchi, M, Marchesi, C, D\u2019Antona, G, Cogiamanian, F, Pisati, F, et al. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant. 2007; 16(6): 563\u201377.","DOI":"10.3727\/000000007783465064"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Hermes, TA, Macedo, AB, Foga\u00e7a, AR, Moraes, LH, de Faria, FM, Kido, LA, et al. Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle. Clin Exp Pharmacol Physiol. 2016; 43(2): 259\u201367.","DOI":"10.1111\/1440-1681.12521"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Eljaszewicz, A, Sienkiewicz, D, Grubczak, K, Okurowska-Zawada, B, Paszko-Patej, G, Miklasz, P, et al. Effect of periodic granulocyte colony-stimulating factor administration on endothelial progenitor cells and different monocyte subsets in pediatric patients with muscular dystrophies. Stem Cells Int. 2016; 2016: 2650849.","DOI":"10.1155\/2016\/2650849"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Scoppetta, C, Grassi, F. Erythropoietin: a new tool for muscle disorders? Med Hypotheses. 2004; 63(1): 73\u20135.","DOI":"10.1016\/j.mehy.2003.12.044"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Lescaudron, L, Pelt\u00e9kian, E, Fontaine-P\u00e9rus, J, Paulin, D, Zampieri, M, Garcia, L, et al. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord. 1999; 9(2): 72\u201380.","DOI":"10.1016\/S0960-8966(98)00111-4"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Madaro, L, Torcinaro, A, De Bardi, M, Contino, FF, Pelizzola, M, Diaferia, GR, et al. Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice. PLoS Genet. 2019; 15(10): e1008408.","DOI":"10.1371\/journal.pgen.1008408"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Hashimoto, T, Ohno, N, Adachi, Y, Yadomae, T. Enhanced production of inducible nitric oxide synthase by beta-glucans in mice. FEMS Immunol Med Microbiol. 1997; 19(2): 131\u20135.","DOI":"10.1016\/S0928-8244(97)00078-3"}],"container-title":["Journal of Smooth Muscle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/59\/0\/59_0543\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:12:26Z","timestamp":1715577146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/59\/0\/59_0543\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":73,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1540\/jsmr.59.67","relation":{},"ISSN":["0916-8737","1884-8796"],"issn-type":[{"value":"0916-8737","type":"print"},{"value":"1884-8796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"0543"}}